Alexion Reports Third Quarter 2019 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Alexion Reports Third Quarter 2019 Results

Alexion Pharmaceuticals (ALXN) PT Lowered to $150 at Oppenheimer

October 24, 2019 9:25 AM EDT

Oppenheimer analyst Hartaj Singh lowered the price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $150.00 (from $165.00) while maintaining a Outperform rating.

The analyst commented, "Alexion (ALXN) reported 3Q19 sales/earnings and provided an investor update on 10/23. The company upgraded its financial guidance for... More

Alexion Pharma (ALXN) Tops Q3 EPS by 32c, Raises FY Guidance

October 23, 2019 6:35 AM EDT

Alexion Pharma (NASDAQ: ALXN) reported Q3 EPS of $2.79, $0.32 better than the analyst estimate of $2.47. Revenue for the quarter came in at $1.26 billion versus the consensus estimate of $1.24 billion.

GUIDANCE:

Alexion Pharma sees FY2019 EPS of $10.25-$10.40, versus the consensus of... More